Literature DB >> 22656272

Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study.

Tsan Yang1, Chi-Hong Chu, Chyi-Huey Bai, San-Lin You, Yu-Ching Chou, Lee-Ching Hwang, Kuo-Liong Chien, Ta-Chen Su, Chin-Hsiao Tseng, Chien-An Sun.   

Abstract

OBJECTIVE: Little is known about serum uric acid (SUA) role for hypertension in the Asian countries with low cardiovascular events. We aimed to explore the relationship in a comprehensive Chinese cohort.
METHODS: Participants in the Taiwanese Survey on Prevalences of Hypertension, Hyperglycemia, and Hyperlipidemia (TwSHHH) who were free of hypertension at baseline recruitment in 2002 (n=3257) were evaluated for the longitudinal association between baseline SUA and blood pressure progression (BPP) and incident hypertension.
RESULTS: During a mean follow-up of 5.41 years, 1119 persons (34.3%) had experienced progression to a higher blood pressure stage and 496 persons (15.2%) had developed hypertension. In multivariate analyses, the adjusted hazard ratios (HRs) [95% confidence intervals (CIs)] comparing the highest and lowest SUA quartiles were 1.78 (1.11-2.02, P for trend .004) for BPP and 1.68 (1.23-2.04, P for trend .028) for incident hypertension. The positively graded relationships between SUA concentration and blood pressure outcomes were observed in both males and females. More interestingly, a statistically significant trend for increasing risk of BPP and incident hypertension across SUA quartiles was most pronounced in participants with abdominal obesity.
CONCLUSION: We concluded that SUA level was an independent predictor of blood pressure progression and incident hypertension in a Chinese population.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22656272     DOI: 10.1016/j.metabol.2012.05.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.

Authors:  L A Ferrara; H Wang; J G Umans; N Franceschini; S Jolly; E T Lee; J Yeh; R B Devereux; B V Howard; G de Simone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-06-19       Impact factor: 4.222

2.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

3.  Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits.

Authors:  Miriam Martínez-Ramírez; Cristóbal Flores-Castillo; L Gabriela Sánchez-Lozada; Rocío Bautista-Pérez; Elizabeth Carreón-Torres; José Manuel Fragoso; José Manuel Rodriguez-Pérez; Fernando E García-Arroyo; Victoria López-Olmos; María Luna-Luna; Gilberto Vargas-Alarcón; Martha Franco; Oscar Pérez-Méndez
Journal:  Lipids       Date:  2017-09-22       Impact factor: 1.880

Review 4.  Hyperuricemia, gout, and cardiovascular disease: an update.

Authors:  Aryeh M Abeles
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

5.  Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study.

Authors:  Y-C Chen; C-A Sun; T Yang; C-H Chu; C-H Bai; S-L You; L-C Hwang; C-H Chen; C-Y Wei; Y-C Chou
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

6.  Serum uric acid is an independent predictor for developing prehypertension: a population-based prospective cohort study.

Authors:  L Liu; Y Gu; C Li; Q Zhang; G Meng; H Wu; H Du; H Shi; Y Xia; X Guo; X Liu; X Bao; Q Su; L Fang; F Yu; H Yang; B Yu; S Sun; X Wang; M Zhou; Q Jia; Q Guo; K Song; G Huang; G Wang; K Niu
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

7.  Serum uric Acid is not an independent risk factor for premature coronary artery disease.

Authors:  Sara Zand; Akbar Shafiee; Mohammadali Boroumand; Arash Jalali; Younes Nozari
Journal:  Cardiorenal Med       Date:  2013-10-24       Impact factor: 2.041

Review 8.  Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.

Authors:  Gemma Currie; Christian Delles
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

9.  The association between blood pressure level and serum uric acid concentration in hemodialysis patients.

Authors:  Jamshid Roozbeh; Mohammad-Mahdi Sagheb; Elaheh Vafaie
Journal:  J Nephropathol       Date:  2015-07-01

10.  Bidirectional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study.

Authors:  An Pan; Gim Gee Teng; Jian-Min Yuan; Woon-Puay Koh
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.